Background Cardio-metabolic risk factors are of increasing concern in HIV-infected
individuals, particularly with the advent of antiretroviral therapy (ART) and the subsequent …

Summary Background Non-communicable diseases (NCDs) are increasing among people
living with HIV (PLHIV), especially in Sub-Saharan Africa (SSA). We determined the …

Aims HIV-infected patients receiving combination antiretroviral therapy may experience
metabolic complications, potentially increasing their risk of cardiovascular diseases (CVDs) …

According to statistics from the World Health Organization,≈ 36.7 million people are
currently living with HIV, and 1.8 million become infected every year. Antiretroviral therapy …

The incidence of vascular events in HIV-infected individuals is increasing. We investigated
whether there is a higher prevalence of vascular risk factors in the adult US population with …

Aims: The aim of this study is to determine the cardiovascular disease (CVD) risk profile of a
large UK HIV cohort and how highly active antiretroviral therapy (HAART) affects this …

Background Long-term antiretroviral therapy has modified the clinical course of HIV infection
to a chronic condition associated with increased risk of developing non-communicable …

Background One of the key risk factors for cardiovascular disease is hypertension.
Hypertension, which leads to heart attacks and strokes, already affects one billion people …

Background: People living with HIV (PLWHIV) have a 2-fold higher risk of having a
cardiovascular event than HIV-negative individuals. Objective: The objective of this article is …

Background and objectives: Cardiovascular disease is a major concern in HIV-infected
patients. Lifetime risk estimations use the risk of developing it over the course of remaining …